WallStSmart
PRE

Prenetics Global Ltd

NASDAQ: PRE · HEALTHCARE · DIAGNOSTICS & RESEARCH

$17.55
-0.19% today

Updated 2026-06-04

Market cap
$319.78M
P/E ratio
P/S ratio
3.46x
EPS (TTM)
$-2.46
Dividend yield
52W range
$7 – $24
Volume
0.2M

Prenetics Global Ltd (PRE) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20032004200520062007200820092010201120122013201420152019202020212022202320242025
Revenue$3.87B$4.17B$4.21B$4.19B$4.15B$4.00B$5.33B$5.90B$5.40B$5.56B$5.59B$6.48B$5.48B$9.23M$65.18M$12.53M$13.16M$21.74M$30.62M$92.39M
Revenue growth (YoY)+7.7%+0.8%-0.4%-0.9%-3.6%+33.3%+10.7%-8.6%+3.1%+0.5%+15.9%-15.4%-99.8%+605.9%-80.8%+5.0%+65.2%+40.8%+201.7%
Cost of revenue$3.37B$3.65B$4.21B$3.27B$3.26B$3.87B$3.56B$4.70B$5.74B$4.15B$4.68B$5.12B$4.76B$6.52M$38.83M$8.93M$9.55M$12.91M$15.22M$43.60M
Gross profit$498.19M$524.07M$917.26M$952.10M$106.85M$1.77B$1.16B$1.41B$860.40M$1.36B$668.70M$2.72M$26.34M$3.60M$3.62M$8.83M$15.40M$48.79M
Gross margin12.9%12.6%0.0%21.9%22.9%2.7%33.2%19.6%0.0%25.3%15.4%21.0%12.2%29.4%40.4%28.7%27.5%40.6%50.3%52.8%
R&D$2.99M$2.78M$6.39M$5.99M$11.66M$10.92M$5.13M
SG&A$13.19M$16.62M$47.93M$59.34M$41.44M$46.73M$45.75M
Operating income$498.19M$524.07M$917.26M$952.10M$106.85M$1.73B$1.09B$1.38B$833.23M$1.33B$642.11M$-20.80M$-995126.00$-56.66M$-66.02M$-51.91M$-48.14M$-38.13M
Operating margin12.9%12.6%0.0%21.9%22.9%2.7%32.4%18.5%0.0%24.8%14.9%20.6%11.7%-225.3%-1.5%-452.1%-501.5%-238.7%-157.2%-41.3%
EBITDA$-18.57M$-1.42M$-209.16M$-218.04M$-47.90M$-51.57M$-32.19M
EBITDA margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%-201.1%-2.2%-1668.9%-1656.3%-220.3%-168.4%-34.8%
EBIT$-20.80M$-3.84M$-216.51M$-225.58M$-55.69M$-57.50M$-35.97M
Interest expense$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$69390.00$59567.00$42229.00$242000.00$119662.00$203000.00$241000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$467.68M$492.35M$749.33M$717.81M$46.57M$1.54B$852.55M$1.13B$664.01M$1.05B$104.38M$-20.14M$-1.94M$-174.01M$-190.45M$-62.72M$-46.30M$-37.71M
Net income growth (YoY)+5.3%-100.0%-4.2%-93.5%+3200.3%-44.5%-100.0%-41.5%+58.9%-90.1%-119.3%+90.4%-8871.0%-9.5%+67.1%+26.2%+18.6%
Profit margin12.1%11.8%0.0%17.9%17.3%1.2%28.8%14.4%0.0%20.4%11.9%16.3%1.9%-218.2%-3.0%-1388.4%-1446.8%-288.5%-151.2%-40.8%

Frequently asked questions

What is Prenetics Global Ltd's revenue?

Prenetics Global Ltd's trailing twelve-month revenue is $92.39M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is PRE?

In its most recent fiscal year, PRE ran a gross margin of 52.81%, an operating margin of -41.27%, and a net margin of -40.82%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does PRE generate?

PRE produced $-22.02M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is PRE's balance sheet healthy?

PRE holds $32.13M in cash and equivalents against — in long-term debt, on $174.60M of shareholder equity. That debt is best read against the cash flow the business throws off each year.